Prevalence of intratumoral regulatory T cells expressing neuropilin-1 is associated with poorer outcomes in patients with cancerChristopher A Chuckran, Dario A.A. Vignali, Jessica Moskovitz et al.|Science Translational Medicine|2021Cited by 38